New eye drug targets both age-related and diabetes-linked vision loss

A new eye drug is now available to treat those who have age-related or diabetes-related vision loss. Developed by the Singapore Eye Research Institute and pharmaceutical firm Roche, it is the first to target both conditions together. The treatment also provides a longer-lasting remedy for patients.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

You May Also Like